Supernus Pharmaceuticals, Inc. Business Finance Contracts & Agreements
42 Contracts & Agreements
- Credit Agreements (1 contract)
- Exchange Agreements (1)
- Indenture Agreements (3)
- Investor Rights Agreements (2)
- Loan Agreements (5)
- Note Agreements (2)
- Purchase Agreements (8)
- Release Agreements (3)
- Security Agreements (1)
- Stock Agreements (5)
- Underwriting Agreements (2)
- Warrant Agreements (9)
- Exhibit 10.1 Credit Line Agreement between UBS Bank USA and Supernus Pharmaceuticals, Inc. dated as of February 8, 2023 (Filed With SEC on February 14, 2023)
- Purchase and Sale Agreement, dated as of June 9, 2006, by and between the Registrant and Rune HealthCare Limited (Filed With SEC on March 8, 2021)
- Asset Purchase and Contribution Agreement, dated as of December (Filed With SEC on March 8, 2021)
- Press Release Dated September 25, 2019 (Filed With SEC on September 25, 2019)
- Press Release Dated August 26, 2019 (Filed With SEC on August 26, 2019)
- Press Release Dated July 23, 2019 (Filed With SEC on July 23, 2019)
- Additional Issuer Warrant Transaction, dated March 15, 2018, between JPMorgan Chase Bank, National Association, London Branch and Supernus Pharmaceuticals, Inc (Filed With SEC on March 20, 2018)
- Additional Issuer Warrant Transaction, dated March 15, 2018, between Bank of America, N.A. and Supernus Pharmaceuticals, Inc (Filed With SEC on March 20, 2018)
- Additional Issuer Warrant Transaction, dated March 15, 2018, between Deutsche Bank AG, London Branch and Supernus Pharmaceuticals, Inc (Filed With SEC on March 20, 2018)
- Base Issuer Warrant Transaction, dated March 14, 2018, between JPMorgan Chase Bank, National Association, London Branch and Supernus Pharmaceuticals, Inc (Filed With SEC on March 20, 2018)
- Base Issuer Warrant Transaction, dated March 14, 2018, between Bank of America, N.A. and Supernus Pharmaceuticals, Inc (Filed With SEC on March 20, 2018)
- Base Issuer Warrant Transaction, dated March 14, 2018, between Deutsche Bank AG, London Branch and Supernus Pharmaceuticals, Inc (Filed With SEC on March 20, 2018)
- Indenture, dated as of March 19, 2018, between Supernus Pharmaceuticals, Inc. and Wilmington Trust, National Association, as trustee (Filed With SEC on March 20, 2018)
- Purchase Agreement, dated March 14, 2018, among Supernus Pharmaceuticals, Inc. and Jefferies LLC, J.P. Morgan Securities LLC and Cowen and Company, LLC (Filed With SEC on March 20, 2018)
- SECURITY AGREEMENT (Filed With SEC on July 8, 2014)
- FIRST SUPPLEMENTAL INDENTURE (Filed With SEC on October 24, 2013)
- CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. COMMERCIAL SUPPLY AGREEMENT (Filed With SEC on February 7, 2013)
- [] Shares Supernus Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on November 26, 2012)
- AMENDMENT NO. 2 TO STOCK RESTRICTION AGREEMENT (Filed With SEC on April 27, 2012)
- STOCK RESTRICTION AGREEMENT (Filed With SEC on April 27, 2012)
- AMENDMENT NO. 2 TO INVESTOR RIGHTS AGREEMENT (Filed With SEC on April 11, 2012)
- SUPERNUS PHARMACEUTICALS, INC. 2012 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on April 11, 2012)
- Supernus Pharmaceuticals, Inc. [ ] Shares Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on April 11, 2012)
- PURCHASE AND SALE AGREEMENT (Filed With SEC on March 16, 2012)
- ASSET PURCHASE AND CONTRIBUTION AGREEMENT dated as of December 22, 2005 among SUPERNUS PHARMACEUTICALS, INC., SHIRE LABORATORIES INC. and SHIRE PLC (Filed With SEC on March 16, 2012)
- UNIT PURCHASE AGREEMENT dated as of December 14, 2011 by and between SUPERNUS PHARMACEUTICALS, INC., and ROYALTY OPPORTUNITIES S.r.I (Filed With SEC on February 14, 2012)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on February 14, 2012)
- WARRANT TO PURCHASE STOCK (Filed With SEC on February 14, 2012)
- SECURED PROMISSORY NOTE (Term B Loan) (Filed With SEC on February 14, 2012)
- SECURED PROMISSORY NOTE - 2 (Term B Loan) (Filed With SEC on February 14, 2012)
- SECURED PROMISSORY NOTE - 1 (Term B Loan) (Filed With SEC on February 14, 2012)
- AMENDED AND RESTATED WARRANT TO PURCHASE STOCK (Filed With SEC on February 14, 2012)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on February 8, 2011)
- INDENTURE dated as of April 15, 2008 by and between TCD ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes described herein, and U.S. BANK NATIONAL... (Filed With SEC on February 8, 2011)
- PURCHASE AND SALE AGREEMENT (Filed With SEC on February 8, 2011)
- ASSET PURCHASE AND CONTRIBUTION AGREEMENT dated as of December 22, 2005 among SUPERNUS PHARMACEUTICALS, INC., SHIRE LABORATORIES INC. and SHIRE PLC (Filed With SEC on February 8, 2011)
- WARRANT TO PURCHASE STOCK (Filed With SEC on February 8, 2011)
- SECURED PROMISSORY NOTE (Filed With SEC on February 8, 2011)
- SECURED PROMISSORY NOTE (Filed With SEC on February 8, 2011)
- INVESTOR RIGHTS AGREEMENT (Filed With SEC on December 23, 2010)
